Summary
The disposition in vitro of nitroglycerin (GTN) and its metabolites in erythrocyte suspensions, plasma and blood has been studied using labelled (3H) and unlabelled GTN and GTN metabolites separated by HPLC. GTN was rapidly metabolised (t1/2 3 min) to dinitro-metabolites and subsequently to the mononitronitrates in erythrocyte suspensions containing a therapeutic concentration of GTN (0.8–10 ng/ml). The metabolism of GTN and its dinitro-metabolites was concentration dependent. GTN and its dinitro-metabolites were plasma protein bound (11–60%). They had an apparent erythrocyte-plasma partition coefficient in the range 0.6 to 0.9. The metabolism of GTN by erythrocytes was partially inhibited by the presence of the dinitro-metabolites of GTN. The metabolism of GTN in blood samples collected from patients could be stopped by adding the collected blood to chilled tubes containing the enzyme inhibitor iodoacetamide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armstrong JA, Slaughter SE, Marks GS, Armstrong PA (1980) Rapid disappearance of nitroglycerin following incubation with human blood. Can J Physiol Pharmacol 58: 454–462
Bennett BM, Nakatsu J, Brien JF, Marks GS (1984) Biotransformation of glyceryl trinitrate by human hemoglobin. Canad J Physiol Pharmacol 62: 704–706
Black CD (1982) Transdermal drug delivery systems. US Pharmacist 7: 49–75
Crouthamel WG, Dorsch B (1979) Specific high-performance liquid chromatographic assay for nitroglycerin in dosage forms. J Pharm Sci 68: 237–238
DiCarlo FJ, Melgar MD (1970) Nitroglycerin biotransformation by rat serum. Biochem Pharmacol 19: 1371–1379
Dunstan I, Griffiths JV, Harvey SA (1965) Nitric esters, part 1. Characterization of the isomeric glycerol dinitrates. Chem Soc (London), pp 1319–1324
Flaherty JT, Reid PR, Kelly DT, Taylor DR, Weisfeldt ML, Pitt B (1975) Intravenous nitroglycerin in acute myocardial infarction. Circulation 51: 132–139
Franciosa JA, Blank RC, Cohen JN (1978) Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. Am J Med 64: 207–211
Gibaldi M, Perrier D (1975) Pharmacokinetics. In: Swarbrick J (ed) Drugs and the pharmaceutical sciences, vol. 1. Marcel Dekker, New York, pp 220–221
Harris PJ, Roubin GS, Sadick NN, Choong CY, Bautovick G, Kelley DT (1983) The effect of high dose intravenous nitroglycerin on cardiovascular hemodynamic features and left ventricular function at rest and during exercise in patients with exertional angina. Am J Cardiol 52: 113A-118A
Heinzow B, Ziegler J (1981) Comparison of the effects of nitroglycerin administered to rats by different routes. J Cardio Vasc Pharmacol 3: 573–580
Imhof PR, Sieber A, Holder J, Muller P, Ott B, Fankhauser P, Chu L-C, Geradin A (1982) Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers. Eur J Clin Pharmacol 23: 99–106
Karim A (1983) Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system. Angiology 34: 11–22
Lang S, Johnson EM, Needleman P (1972) Metabolism of and vascular responses to glyceryl trinitrate in the eviscerated rat. Biochem Pharmacol 21: 422–424
Lee HL (1973) The metabolism of glyceryl trinitrate by liver and blood from different species. Biochem Pharmacol 22: 3122–3124
Maier GA, Poliszczuk A, Fung HL (1979) Stability of nitroglycerin in human and rat plasma. Int J Pharm 4: 75–82
Marcus CJ, Habig WH, Jakoby WB (1978) Glutathione transferase from human erythrocytes — nonidentity with enzymes from liver. Arch Biochem Biophys 188: 287–293
McNiff EF, Yacobi A, Young-Chang FM, Golden LH, Goldfarb A, Fung HL (1981) Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. J Pharm Sci 70: 1054–1058
Mircevova L, Pick P, Fleiserova J (1977) The effect of various drugs on passive permeability of Na and K in human erythrocytes. Arch Int Physiol Biochim 85: 317–321
Noonan PK, Benet LZ (1982) Formation of mono- and dinitrate metabolites of nitroglycerin following incubation with human blood. Int J Pharm 12: 331–340
Pedersen PV (1977) Curve fitting and modelling in pharmacokinetics and some practical experiments with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm 5: 513–531
Rey E, Daoud El-Assaf H, Richard MO et al. (1983) Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects. Eur J Clin Pharmacol 25: 779–782
Roberts R (1983) Intravenous nitroglycerin in acute myocardial infarction. Am J Med 74: 45–52
Rowland M, Tozer TN (1980) Clinical pharmacokinetics: Concepts and applications. Lea & Febiger, Philadelphia, pp 277–278
Sokoloski TD, Wu CC, Wu LS, Burkman AM (1983) Interaction of nitroglycerin with human blood components. J Pharm Sci 72: 335–338
Taylor IW, Ioannides C, Turner JC, Koenigsberger RV, Parke DV (1981) Micro determination of glyceryl trinitrate in biological fluids; effect of deuteration of glyceryl trinitrate on its pharmacokinetic properties. J Pharm Pharmacol 33: 244–246
Wu CC, Sokoloski T, Blanford MF, Burkman AM (1981) Absence of metabolite in the disappearance of nitroglycerin following incubation with red blood cells. Int J Pharm 8: 323–329
Yap PSK, McNiff EF, Fung HL (1978) Improved GLC determination of plasma nitroglycerin concentrations. J Pharm Sci 67: 582–584
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cossum, P.A., Roberts, M.S. Nitroglycerin disposition in human blood. Eur J Clin Pharmacol 29, 169–175 (1985). https://doi.org/10.1007/BF00547417
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00547417